APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,382,674 | -58.1% | 62,636 | +0.2% | 0.01% | -53.8% |
Q2 2023 | $5,692,475 | +206.9% | 62,486 | +122.2% | 0.01% | +225.0% |
Q1 2023 | $1,854,531 | +27.6% | 28,116 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,453,878 | -23.9% | 28,116 | +0.5% | 0.00% | -20.0% |
Q3 2022 | $1,910,000 | +51.0% | 27,966 | 0.0% | 0.01% | +66.7% |
Q2 2022 | $1,265,000 | -7.1% | 27,966 | +4.4% | 0.00% | 0.0% |
Q1 2022 | $1,362,000 | +7.5% | 26,796 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $1,267,000 | +43.5% | 26,796 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $883,000 | -47.9% | 26,796 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $1,694,000 | +65.3% | 26,796 | +12.1% | 0.00% | +50.0% |
Q1 2021 | $1,025,000 | -26.0% | 23,895 | -1.3% | 0.00% | -33.3% |
Q4 2020 | $1,385,000 | +84.2% | 24,215 | -2.8% | 0.00% | +50.0% |
Q3 2020 | $752,000 | +1.5% | 24,915 | +9.8% | 0.00% | 0.0% |
Q2 2020 | $741,000 | +35.2% | 22,695 | +11.0% | 0.00% | 0.0% |
Q1 2020 | $548,000 | +3.2% | 20,447 | +17.9% | 0.00% | +100.0% |
Q4 2019 | $531,000 | +28.3% | 17,347 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $414,000 | -5.0% | 17,187 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $436,000 | +79.4% | 17,187 | +37.9% | 0.00% | 0.0% |
Q1 2019 | $243,000 | +48.2% | 12,467 | 0.0% | 0.00% | – |
Q4 2018 | $164,000 | -14.6% | 12,467 | +15.3% | 0.00% | – |
Q3 2018 | $192,000 | – | 10,808 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |